Techspace Member Heidi Health Raises $65 M Series B to Build an AI Care Partner for Every Clinician

LONDON — October 2025 — Techspace member Heidi Health, a leader in AI-powered clinician productivity tools, today announced a $65 million Series B funding round led by Point72 Private Investments, with participation from existing backers including Blackbird Ventures, Headline and Latitude (the growth fund of Phoenix Court).  

This round values Heidi Health at US$465 million, and brings the company’s total funding close to US$100 million.  

Heidi Health’s platform automates key administrative tasks for clinicians — from documentation and evidence-search to follow-up communications — magnifying clinical capacity and allowing care providers to spend more time with patients. In the last 18 months the company has already returned more than 18 million clinician hours.  

“It is untenable that healthcare demand continues to rise while clinical time continues to shrink… That’s why I founded Heidi: to build an AI Care Partner that stands alongside clinicians,” said Dr Thomas Kelly, CEO and co-founder of Heidi Health.

With this new funding, Heidi Health will accelerate expansion of head-count and local operations in the USA, UK and Canada, and scale adoption in key markets such as France, Germany, Spain, South Africa, Singapore and Hong Kong.  

At Techspace, we’re proud to host Heidi Health’s team in our London network of high-growth companies. Their mission aligns perfectly with our community: enabling ambitious tech firms to scale fast, innovate boldly and solve real-world problems.

“Heidi Health represents the best of Australia’s fast-growing AI scene — ambitious, impactful, and bold. It’s a privilege to support their UK team as they scale globally.” said Charli Stanger-Leathes.

‍

About Techspace

Techspace provides workspace, community and growth support for scaling technology companies across London and Berlin, helping them connect, build and scale faster.

‍

About Heidi Health

Heidi Health builds an AI Care Partner for clinicians worldwide. The company’s platform supports more than 2 million consults per week, in 110 languages, across 116 countries.  

‍